What is the Impact of Rheumatoid Factor Positivity on the Real-world Effectiveness of Infliximab Treatment in Rheumatoid Arthritis?

被引:0
|
作者
Choquette, Denis [1 ]
Faraawi, Rafat
Zummer, Michel [2 ]
Chow, Andrew [3 ]
Kelsall, John [4 ,5 ]
Rampakakis, Emmanouil [6 ,7 ]
Sampalis, John [8 ,9 ]
Otawa, Susan [10 ]
Lehman, Allen [10 ]
Shawl, May [10 ]
机构
[1] Hop Notre Dame de Bon Secours, Montreal, PQ H2L 4K8, Canada
[2] CH Maisonneuve Rosemont, Montreal, PQ, Canada
[3] Univ Toronto, McMaster Univ, Credit Valley Rheumatol, Mississauga, ON L5L 1C6, Canada
[4] Univ British Columbia, Mary Pack Arthrit Ctr, Vancouver, BC V5Z 1M9, Canada
[5] Univ British Columbia, Div Rheumatol, St Pauls Hosp, Vancouver, BC V5Z 1M9, Canada
[6] JSS Med Res, St Laurent, PQ, Canada
[7] McGill Univ, St Laurent, PQ, Canada
[8] McGill Univ, Westmount, PQ, Canada
[9] Univ Montreal, Westmount, PQ, Canada
[10] Janssen Inc, Toronto, ON, Canada
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
30
引用
收藏
页码:965 / 965
页数:1
相关论文
共 50 条
  • [21] Corticosteroid Use in Rheumatoid Arthritis Patients on Infliximab: Treatment Implications and Impact on Durability of Response Based on a Real-World Canadian Population
    Haraoui, Boulos
    Jovaisas, Algis
    Bensen, William
    Faraawi, Rafat
    Kelsall, John
    Dixit, Sanjay
    Rampakakis, Emmanouil
    Sampalis, John
    Nantel, Francois
    Otawa, Susan
    Lehman, Allen
    Shawi, May
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (07) : 1444 - 1445
  • [22] Real world costs and dosing patterns of abatacept and infliximab for the treatment of rheumatoid arthritis
    Trivedi, D. N.
    Kreilick, C.
    Rosenblatt, L. C.
    VALUE IN HEALTH, 2008, 11 (03) : A263 - A263
  • [23] Real-World Comparative Effectiveness of Tofacitinib and Tumor Necrosis Factor Inhibitors as Monotherapy and Combination Therapy for Treatment of Rheumatoid Arthritis
    George W. Reed
    Robert A. Gerber
    Ying Shan
    Liza Takiya
    Kimberly J. Dandreo
    David Gruben
    Joel Kremer
    Gene Wallenstein
    Rheumatology and Therapy, 2019, 6 : 573 - 586
  • [24] Real-World Comparative Effectiveness of Tofacitinib and Tumor Necrosis Factor Inhibitors as Monotherapy and Combination Therapy for Treatment of Rheumatoid Arthritis
    Reed, George W.
    Gerber, Robert A.
    Shan, Ying
    Takiya, Liza
    Dandreo, Kimberly J.
    Gruben, David
    Kremer, Joel
    Wallenstein, Gene
    RHEUMATOLOGY AND THERAPY, 2019, 6 (04) : 573 - 586
  • [25] Real-world evaluation of effectiveness, persistence, and usage patterns of tofacitinib in treatment of rheumatoid arthritis in Australia
    Paul Bird
    Geoffrey Littlejohn
    Belinda Butcher
    Tegan Smith
    Candida da Fonseca Pereira
    David Witcombe
    Hedley Griffiths
    Clinical Rheumatology, 2020, 39 : 2545 - 2551
  • [26] Real-world evaluation of effectiveness, persistence, and usage patterns of tofacitinib in treatment of rheumatoid arthritis in Australia
    Bird, Paul
    Littlejohn, Geoffrey
    Butcher, Belinda
    Smith, Tegan
    Pereira, Candida da Fonseca
    Witcombe, David
    Griffiths, Hedley
    CLINICAL RHEUMATOLOGY, 2020, 39 (09) : 2545 - 2551
  • [27] Rheumatoid Arthritis Real-World Data on Biosimilars
    Walter, Monika
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2020, 117 (33-34): : A1566 - A1566
  • [28] Corticosteroid use in Rheumatoid Arthritis Patients Taking Infliximab: Treatment Implications Based on a Real-world Canadian Population
    Haraoui, Boulos
    Jovaisas, Algis
    Bensen, William
    Faraawi, Rafat
    Dixit, Sanjay
    Rampakakis, Emmanouil
    Nantel, Francois
    Otawa, Susan
    Lehman, Allen
    Shawi, May
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 961 - 962
  • [29] Impact of treatment with infliximab on anticyclic citrullinated peptide antibody and rheumatoid factor in patients with rheumatoid arthritis.
    Mubashir, E
    Ahmed, MM
    Wolf, RE
    Hayat, S
    Hall, VC
    Shi, R
    Berney, SM
    JOURNAL OF INVESTIGATIVE MEDICINE, 2006, 54 (01) : S284 - S284
  • [30] Use of corticosteroids in patients with rheumatoid arthritis treated with infliximab: treatment implications based on a real-world Canadian population
    Haraoui, Boulos
    Jovaisas, Algis
    Bensen, William G.
    Faraawi, Rafat
    Kelsall, John
    Dixit, Sanjay
    Rodrigues, Jude
    Sheriff, Maqbool
    Rampakakis, Emmanouil
    Sampalis, John S.
    Lehman, Allen J.
    Otawa, Susan
    Nantel, Francois
    Shawi, May
    RMD OPEN, 2015, 1 (01):